Kennedy P, Fultz M, Phares J, Yu X
Biomolecules. 2024; 14(10).
PMID: 39456143
PMC: 11506455.
DOI: 10.3390/biom14101210.
Zhou W, Graner M, Beseler C, Domashevich T, Selva S, Webster G
Clin Immunol. 2023; 256:109801.
PMID: 37816415
PMC: 11830478.
DOI: 10.1016/j.clim.2023.109801.
Zhou W, Graner M, Paucek P, Beseler C, Boisen M, Bubak A
Cell Death Dis. 2023; 14(4):254.
PMID: 37031195
PMC: 10082781.
DOI: 10.1038/s41419-023-05783-3.
Al-Ani M, Elemam N, Hachim I, Raju T, Muhammad J, Hachim M
J Inflamm Res. 2021; 14:2601-2617.
PMID: 34168483
PMC: 8216756.
DOI: 10.2147/JIR.S310535.
Morgan B, Gommerman J, Ramaglia V
Front Cell Neurosci. 2021; 14:600656.
PMID: 33488361
PMC: 7817777.
DOI: 10.3389/fncel.2020.600656.
The Role of Antibodies in the Pathogenesis of Multiple Sclerosis.
Yu X, Graner M, Kennedy P, Liu Y
Front Neurol. 2020; 11:533388.
PMID: 33192968
PMC: 7606501.
DOI: 10.3389/fneur.2020.533388.
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.
Chamberlain J, Huda S, Whittam D, Matiello M, Morgan B, Jacob A
J Neurol. 2019; 268(5):1643-1664.
PMID: 31482201
DOI: 10.1007/s00415-019-09498-4.
The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C, Vollmer T, Graner M, Yu X
PLoS One. 2017; 12(10):e0186842.
PMID: 29059249
PMC: 5653326.
DOI: 10.1371/journal.pone.0186842.
Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.
Bamm V, Geist A, Harauz G
Metab Brain Dis. 2016; 32(1):19-34.
PMID: 27807673
DOI: 10.1007/s11011-016-9923-x.
Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
Kallaur A, Reiche E, Oliveira S, Simao A, de Carvalho Jennings Pereira W, Alfieri D
Mol Neurobiol. 2016; 54(1):31-44.
PMID: 26732588
DOI: 10.1007/s12035-015-9648-6.
The Ins and Outs of B Cells in Multiple Sclerosis.
Blauth K, Owens G, Bennett J
Front Immunol. 2015; 6:565.
PMID: 26594215
PMC: 4633507.
DOI: 10.3389/fimmu.2015.00565.
Complementing the inflammasome.
Triantafilou M, Hughes T, Morgan B, Triantafilou K
Immunology. 2015; 147(2):152-64.
PMID: 26572245
PMC: 4717242.
DOI: 10.1111/imm.12556.
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Caligiuri M, Barone S, Cherubini A, Augimeri A, Chiriaco C, Trotta M
Neuroimage Clin. 2015; 7:28-33.
PMID: 25610764
PMC: 4299954.
DOI: 10.1016/j.nicl.2014.11.008.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Ingram G, Loveless S, Howell O, Hakobyan S, Dancey B, Harris C
Acta Neuropathol Commun. 2014; 2:53.
PMID: 24887075
PMC: 4048455.
DOI: 10.1186/2051-5960-2-53.
Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.
Hu X, Tomlinson S, Barnum S
Neurosci Lett. 2012; 531(1):35-9.
PMID: 23079547
PMC: 3498843.
DOI: 10.1016/j.neulet.2012.10.012.
Systemic complement profiling in multiple sclerosis as a biomarker of disease state.
Ingram G, Hakobyan S, Hirst C, Harris C, Loveless S, Mitchell J
Mult Scler. 2012; 18(10):1401-11.
PMID: 22354735
PMC: 3697901.
DOI: 10.1177/1352458512438238.
The effect of smoking on the symptoms and progression of multiple sclerosis: a review.
Shirani A, Tremlett H
J Inflamm Res. 2011; 3:115-26.
PMID: 22096361
PMC: 3218727.
DOI: 10.2147/JIR.S12059.
Complement in the brain.
Veerhuis R, Nielsen H, Tenner A
Mol Immunol. 2011; 48(14):1592-603.
PMID: 21546088
PMC: 3142281.
DOI: 10.1016/j.molimm.2011.04.003.
Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.
Kolappan M, Henderson A, Jenkins T, Wheeler-Kingshott C, Plant G, Thompson A
J Neurol. 2009; 256(3):305-19.
PMID: 19296047
DOI: 10.1007/s00415-009-0123-z.
First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T.
Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn J, Kraff O
AJNR Am J Neuroradiol. 2009; 30(4):699-702.
PMID: 19147714
PMC: 7051774.
DOI: 10.3174/ajnr.A1434.
